Stemtech Corp Files 8-K: Regulation FD Disclosure

TL;DR

Stemtech Corp filed an 8-K on Dec 30, 2024 for a Reg FD disclosure.

AI Summary

Stemtech Corporation filed an 8-K on January 3, 2025, reporting an event on December 30, 2024. The filing is a Regulation FD Disclosure. The company was formerly known as Globe Net Wireless Corp. until February 1, 2011.

Why It Matters

This 8-K filing serves as a public disclosure of material information by Stemtech Corporation, ensuring compliance with SEC regulations and informing investors.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediate negative or positive financial events.

Key Players & Entities

• Stemtech Corporation (company) — Registrant
• Globe Net Wireless Corp. (company) — Former company name
• December 30, 2024 (date) — Earliest event date
• January 3, 2025 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — h registered Common Stock , par value $0.001 STEK OTCQB Indicate by check mark

Filing Documents

• stemtech_8k.htm (8-K) — 38KB
• 0001683168-25-000068.txt ( ) — 209KB
• stek-20241230.xsd (EX-101.SCH) — 3KB
• stek-20241230_lab.xml (EX-101.LAB) — 33KB
• stek-20241230_pre.xml (EX-101.PRE) — 22KB
• stemtech_8k_htm.xml (XML) — 4KB

01

Item 7.01 Regulation FD Stemtech Corporation (the "Company") has terminated its previously reported non-binding Letter of Intent (LOI) for a proposed Reverse Takeover (RTO) of Eevia Health Plc. Upon further due diligence, the Company has determined that Evia Health Plc could not meet the deadlines necessary to make this RTO, and has terminated its plans with Eevia Health Plc. The Company and Seacret Direct, LLC d/b/a/ Viago ("Viago") remain committed to their previously disclosed agreement whereby the two companies will merge. The companies are now in negotiations to merge into a company listed on the Swedish MTF Nordic SME Sweden, a part of the Nordic Growth Market (NGM), though no definitive agreement has yet been executed. The proposed RTO will be subject to additional conditions, including an exemption from the obligation to make a bid from the Swedish Securities Council and compliance with other regulatory requirements, the negotiation and execution of definitive agreements, including mutually accepted representations, warranties and covenants.

Forward-Looking Statements

Forward-Looking Statements Certain statements made in this Current Report are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "target," "believe," "expect," "will," "shall," "may," "anticipate," "assume," "estimate," "would," "could," "positioned," "future," "forecast," "intend," "plan," "project," "outlook" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this Current Report regarding: the proposed transactions contemplated by the merger agreement, including the benefits of the proposed business combination, integration plans, expected synergies and revenue opportunities; anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, continued expansion of product portfolios and the availability or effectiveness of the technology for such products; the longevity health care sector's continued growth; and the expected timing of the proposed business combination. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking s

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 3 rd , 2025 Stemtech Corporation By: /s/ Charles Arnold Charles Arnold, CEO 3

View Full Filing

View this 8-K filing on SEC EDGAR